We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$11.2B
AUM Growth
+$4.26B
Cap. Flow
+$3.84B
Cap. Flow %
34.3%
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294

Sector Composition

Rank Sector Weight
1 Technology 17.31%
2 Healthcare 16.38%
3 Financials 13.99%
4 Communication Services 7.66%
5 Consumer Discretionary 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRNT
276
DELISTED
IronNet, Inc.
IRNT
$4.71M 0.04%
471,834
-1,813
-0.4% -$18K
LSI
277
DELISTED
Life Storage, Inc.
LSI
$4.65M 0.04%
43,285
+8,385
+24% +$825K
CRU
278
DELISTED
Crucible Acquisition Corporation
CRU
$4.61M 0.04%
474,983
UDR icon
279
UDR
UDR
$12.3B
$4.6M 0.04%
+94,000
New +$4.42M
QFIN icon
280
Qfin Holdings
QFIN
$1.59B
$4.6M 0.04%
110,000
-40,000
-27% -$1.22M
CTAC
281
DELISTED
Cerberus Telecom Acquisition Corp.
CTAC
$4.46M 0.04%
449,452
-7,557
-2% -$75K
NTST
282
NETSTREIT Corp
NTST
$2.14B
$4.46M 0.04%
193,400
+56,800
+42% +$1.24M
AZRE
283
DELISTED
Azure Power Global Limited
AZRE
$4.42M 0.04%
164,324
+40,523
+33% +$940K
GBTG icon
284
American Express Global Business Travel
GBTG
$4.93B
$4.42M 0.04%
451,762
YAC
285
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
$4.4M 0.04%
445,971
-54,011
-11% -$533K
CTV
286
DELISTED
Innovid Corp.
CTV
$4.37M 0.04%
+441,966
New +$4.41M
COCH icon
287
Envoy Medical
COCH
$52.4M
$4.36M 0.04%
+449,804
New +$4.37M
KLAQ
288
DELISTED
KL Acquisition Corp Class A Common Stock
KLAQ
$4.36M 0.04%
449,786
FINM
289
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
$4.36M 0.04%
449,983
LDTC
290
DELISTED
LeddarTech
LDTC
$4.36M 0.04%
898,782
-100,392
-10% -$491K
TMAC
291
DELISTED
The Music Acquisition Corporation
TMAC
$4.35M 0.04%
449,983
KRC icon
292
Kilroy Realty
KRC
$4.34B
$4.34M 0.04%
62,300
+29,400
+89% +$2.04M
WH icon
293
Wyndham Hotels & Resorts
WH
$5.58B
$4.3M 0.04%
59,540
+13,440
+29% +$993K
SRNG
294
DELISTED
Soaring Eagle Acquisition Corp. Class A Ordinary Share
SRNG
$4.21M 0.04%
+422,847
New +$4.22M
ARVL
295
DELISTED
Arrival Ordinary Shares
ARVL
$4.16M 0.04%
5,305
+3,379
+175% +$2.99M
SWET
296
DELISTED
Athlon Acquisition Corp. Class A Common stock
SWET
$4.11M 0.04%
424,787
-50,196
-11% -$487K
DOC
297
DELISTED
PHYSICIANS REALTY TRUST
DOC
$4.07M 0.04%
220,300
+104,600
+90% +$1.95M
DISA
298
DELISTED
Disruptive Acquisition Corporation I Class A Ordinary Shares
DISA
$4.07M 0.04%
+419,135
New +$4.08M
BHIL
299
DELISTED
Benson Hill, Inc.
BHIL
$4.05M 0.04%
11,686
+8,005
+217% +$2.81M
FZT
300
DELISTED
FAST Acquisition Corp. II
FZT
$4.03M 0.04%
+411,849
New +$4.02M

Similar funds

UBS O'Connor's Q2 2021 Portfolio in Review

As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

UBS O'Connor deployed $3.84B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.

  • UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
  • UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
  • UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
  • UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
  • UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
  • UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
  • UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.